Fortrea Holdings (FTRE) Share-based Compensation (2022 - 2026)

Fortrea Holdings (FTRE) posted Share-based Compensation of $11.4 million for Q1 2026, down 84.68% on a QoQ basis from $74.4 million in Q4 2025, and down 21.92% year-over-year from $14.6 million in Q1 2025.

Fortrea Holdings (FTRE) Share-based Compensation (2022 - 2026) Analysis & Trends

Fortrea Holdings' Share-based Compensation history runs 5 years deep, the most recent figure standing at $11.4 million for Q1 2026.

  • Quarterly Share-based Compensation fell 21.92% year-over-year to $11.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $71.2 million (up 22.97% YoY) and the FY2025 annual result came in at $74.4 million, up 27.4% from the prior year.
  • Share-based Compensation was $11.4 million for Q1 2026 at Fortrea Holdings, down from $74.4 million in the prior quarter.
  • Across five years, Share-based Compensation topped out at $74.4 million in Q4 2025 and bottomed at -$37.3 million in Q3 2025.
  • A 5-year average of $13.3 million and a median of $13.0 million in 2024 frame the typical range for Share-based Compensation.
  • Peak annual rise in Share-based Compensation reached 386.27% in 2025, while the deepest fall reached 386.92% in 2025.
  • Fortrea Holdings' Share-based Compensation stood at $5.8 million in 2022, then soared by 167.24% to $15.5 million in 2023, then retreated by 1.29% to $15.3 million in 2024, then soared by 386.27% to $74.4 million in 2025, then slumped by 84.68% to $11.4 million in 2026.
  • Business Quant data shows FTRE's Share-based Compensation at $11.4 million in Q1 2026, $74.4 million in Q4 2025, and -$37.3 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Share-based Compensation (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 6.39 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 9.26 Mn
4 NuCana 279.75 Bn 279.75 Bn - 1.18 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 166.40 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 257.40 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 87.30 Mn
10 Fortrea Holdings 1.83 Bn 1.68 Bn 123.60 Mn 11.40 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 11.40 Mn
Mar 31, 2026 11.40 Mn
Dec 31, 2025 74.40 Mn
Dec 31, 2025 74.40 Mn
Sep 30, 2025 -37.30 Mn
Sep 30, 2025 -37.30 Mn
Jun 30, 2025 22.70 Mn
Jun 30, 2025 22.70 Mn
Mar 31, 2025 14.60 Mn
Mar 31, 2025 14.60 Mn
Dec 31, 2024 15.30 Mn
Dec 31, 2024 15.30 Mn
Sep 30, 2024 13.00 Mn
Sep 30, 2024 13.00 Mn
Jun 30, 2024 15.00 Mn
Jun 30, 2024 15.00 Mn
Mar 31, 2024 15.10 Mn
Mar 31, 2024 15.10 Mn
Dec 31, 2023 15.50 Mn
Dec 31, 2023 15.50 Mn